FDA seeks comment on pedigree technologies

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

Lani Bertrand, RPh, joins the latest episode of Over The Counter to discuss the role of technology in easing burnout during the COVID-19 pandemic.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

Drug Topics met with Lourdes Cross, PharmD, BCACP, CDCES, to discuss pharmacists’ role in managing patients’ chronic obstructive pulmonary disease.